Active ingredientNabumetoneCat. No. P-N001-001CAS 42924-53-8Family · Pharmaceutical analytical standards
Nabumetone
A naphthalene-derived non-steroidal anti-inflammatory drug, used to relieve pain and inflammation in osteoarthritis and rheumatoid arthritis; it was approved in the United States in 1991. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Unlike most anti-inflammatories it is not an acid: it is an almost inactive prodrug that the liver converts into the real active substance, 6-MNA.
Go to the active ingredient →Active ingredientNabumetoneCat. No. P-N001-001CAS 42924-53-8
Pharmacopoeial impurityNabumetone EP Impurity ACat. No. P-N001-002CAS 343272-52-6
Pharmacopoeial impurityNabumetone EP Impurity BCat. No. P-N001-003CAS 343272-51-5
Pharmacopoeial impurityNabumetone EP Impurity CCat. No. P-N001-004CAS 65726-24-1
Pharmacopoeial impurityNabumetone EP Impurity ECat. No. P-N001-005CAS 343272-53-7
Pharmacopoeial impurityNabumetone EP Impurity FCat. No. P-N001-006CAS 29619-45-2
Pharmacopoeial impurityNabumetone USP Related Compound ACat. No. P-N001-007CAS 127053-22-9
Isotopically labelledNabumetone-d3Cat. No. P-N001-008CAS 1216770-08-9
ImpurityNabumetone Impurity 1Cat. No. P-N001-009CAS 56600-90-9No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceNabumetone CRSEDQM code N0020000Family NabumetoneImpurityNabumetone impurity D CRSEDQM code N0020020Family NabumetoneImpurityNabumetone impurity F CRSEDQM code N0020030Family NabumetoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.